首页 > 最新文献

European Journal of Hospital Pharmacy: Science and Practice最新文献

英文 中文
4CPS-283 Oncohaematological pharmaceutical care consultation. Is the information on the European Public Assessment Report of drugs enough? 4CPS-283血液肿瘤药学服务咨询。欧洲药品公共评估报告的信息是否足够?
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.115
V. Arroyo, A. H. López, C. Munoz, R. Caballero, M. Sánchez, A. Martínez, Clara Magdalena Martínez Hernández
{"title":"4CPS-283 Oncohaematological pharmaceutical care consultation. Is the information on the European Public Assessment Report of drugs enough?","authors":"V. Arroyo, A. H. López, C. Munoz, R. Caballero, M. Sánchez, A. Martínez, Clara Magdalena Martínez Hernández","doi":"10.1136/EJHPHARM-2021-EAHPCONF.115","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.115","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84737440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-366 Comparing the medication process across countries using the functional resonance analysis method 4CPS-366使用功能共振分析法比较各国用药过程
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.198
CF Bech, Trh Andersen, T. Graabaek
{"title":"4CPS-366 Comparing the medication process across countries using the functional resonance analysis method","authors":"CF Bech, Trh Andersen, T. Graabaek","doi":"10.1136/EJHPHARM-2021-EAHPCONF.198","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.198","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88647233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-359 Development and validation of a 30 day revisit risk prediction model in patients admitted to the emergency department due to drug related problems 4CPS-359药物相关问题致急诊科患者30天重访风险预测模型的开发与验证
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.191
J. R. Ramos, L. G. Martin, A. Borrego, N. M. Malagarriga, D. M. Catalan, N. Beltran, M. Bafalluy
{"title":"4CPS-359 Development and validation of a 30 day revisit risk prediction model in patients admitted to the emergency department due to drug related problems","authors":"J. R. Ramos, L. G. Martin, A. Borrego, N. M. Malagarriga, D. M. Catalan, N. Beltran, M. Bafalluy","doi":"10.1136/EJHPHARM-2021-EAHPCONF.191","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.191","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91188079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6ER-034 Medication deprescribing and follow-up: a survey among subacute multimorbid patients in a multidisciplinary outpatient clinic 6ER-034药物处方和随访:对多学科门诊亚急性多病患者的调查
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.358
A. Aharaz, P. Fabricius, J. H. Rasmussen, H. Mcnulty, A. Cyron, A. Bengaard, M. Schiøtz, R. L. Simonsen, Charlotte Treldal, M. B. Houlind
{"title":"6ER-034 Medication deprescribing and follow-up: a survey among subacute multimorbid patients in a multidisciplinary outpatient clinic","authors":"A. Aharaz, P. Fabricius, J. H. Rasmussen, H. Mcnulty, A. Cyron, A. Bengaard, M. Schiøtz, R. L. Simonsen, Charlotte Treldal, M. B. Houlind","doi":"10.1136/EJHPHARM-2021-EAHPCONF.358","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.358","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89446088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-249 Second generation β-lactam/β-lactamase inhibitor combinations: ceftazidime–avibactam and ceftolozane–tazobactam experience of use 第二代β-内酰胺/β-内酰胺酶抑制剂联合使用:头孢他啶-阿维巴坦和头孢洛赞-他唑巴坦使用经验
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.81
M. Pérez, E. M. Ruiz, G. Lazaro, I. M. Acosta, P. Molina, C. D. Barahona, Á. Gutiérrez, M. Crespo, A. Lopez, A. H. Hernández
{"title":"4CPS-249 Second generation β-lactam/β-lactamase inhibitor combinations: ceftazidime–avibactam and ceftolozane–tazobactam experience of use","authors":"M. Pérez, E. M. Ruiz, G. Lazaro, I. M. Acosta, P. Molina, C. D. Barahona, Á. Gutiérrez, M. Crespo, A. Lopez, A. H. Hernández","doi":"10.1136/EJHPHARM-2021-EAHPCONF.81","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.81","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84486453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-323 Evaluation of the use, adherence and tolerance of 0.03% tacrolimus eye drops 0.03%他克莫司滴眼液的使用、依从性和耐受性评价
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.155
I. V. Rey, M. González-Barcia, L. García-Quintanilla, A. Castro-Balado, M. Busto-Iglesias, I. Zarra-Ferro, A. Fernández-Ferreiro
{"title":"4CPS-323 Evaluation of the use, adherence and tolerance of 0.03% tacrolimus eye drops","authors":"I. V. Rey, M. González-Barcia, L. García-Quintanilla, A. Castro-Balado, M. Busto-Iglesias, I. Zarra-Ferro, A. Fernández-Ferreiro","doi":"10.1136/EJHPHARM-2021-EAHPCONF.155","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.155","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87536853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
5PSQ-193 Patient safety in medication dispensing performed by pharmaconomists: a before and after study 5PSQ-193药理学家配药过程中的患者安全:前后对比研究
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.312
C. Sorensen, L. Aggergaard, B Dorthe Krogsgaard
Background and importance High patient safety is a top priority in healthcare systems worldwide. To secure high patient safety, previous research have focused on different medication concepts (eg, automatic medication dispensing, nurse led medication dispensing or self-administration by patients). However, resources are scarce and decision makers want the most ‘value for money’. Therefore, hospital managers investigated the patient safety of medication dispensing performed by pharmaconomists (pharmacy technician with a 3 year degree (180 European credit transfer system points)) compared with nurses. Aim and objectives To evaluate patient safety of ward level medication dispensing performed by pharmaconomists compared with nurse led medication dispensing. Material and methods Medication dispensing by pharmaconomists was implemented at seven hospital wards in January 2020. The study was designed as a before and after study. The proportion of ward level dispensing errors was collected through disguised observation of nurses and pharmaconomists in the medicine room before and after implementation of pharmaconomist led medication dispensing. Before data (control group) stem from a PhD study (by the main author) at the same hospital. These data were collected in 2017–2018 by observing 37 nurses in one ward. After data (intervention group) were collected in March and June 2020. After data were collected in seven wards, to increase the number of pharmaconomists observed (9 instead of only 1) and thus increase generalisability. The collection of after data was performed over two periods due to COVID-19 restrictions at the hospital. A dispensing error was defined as a deviation between the prescription and the dispensed medication (eg, wrong dose). Opportunity for errors (OEs) was defined as any medication dispensed and any medication prescribed but not dispensed. Dispensing error proportion=(dispensing errors/OEs) × 100%. Results In the control group (before data), 1028 OEs were observed, covering 120 patients. In the intervention group (after data), 1036 OEs were observed, covering 122 patients. The dispensing error proportion was 2.2% (95% CI 1.4 to 3.3%) in the intervention group (23 errors) compared with 12.8% (95% CI 10.9 to 15.0) in the control group (132 errors). The difference between groups was statistically significant (p=0.00). Conclusion and relevance As pharmaconomists made fewer dispensing errors compared with nurse led medication dispensing, the results indicate high patient safety when medication is dispensed by pharmaconomists. Medication dispensing by pharmaconomists may therefore be a safe alternative to nurse led medication dispensing. References and/or acknowledgements Conflict of interest No conflict of interest
背景和重要性:患者安全是全球医疗保健系统的重中之重。为了确保患者的高度安全,以前的研究主要集中在不同的用药概念上(例如,自动配药,护士主导的配药或患者自我给药)。然而,资源是稀缺的,决策者希望获得最大的“物有所值”。因此,医院管理人员调查了药理学家(具有3年学位的药学技术人员(180欧洲学分转换系统积分))与护士进行药物调剂的患者安全性。目的与目的比较药理学家进行病房级药物调剂与护士主导药物调剂的患者安全性。材料和方法2020年1月,在7个医院病房实施药理学员配药。该研究被设计为前后研究。通过对实施药理学家主导药品调剂前后医务室护士和药理学家的变相观察,收集病房级调剂差错比例。之前的数据(对照组)来自同一家医院的博士研究(主要作者)。这些数据是在2017-2018年通过观察一个病房的37名护士收集的。于2020年3月和6月收集数据(干预组)。在收集了7个病区的数据后,增加了观察的药理学家的数量(9个而不是只有1个),从而增加了普遍性。由于医院对COVID-19的限制,后续数据的收集分两个时间段进行。配药错误被定义为处方与配药之间的偏差(例如,剂量错误)。错误机会(OEs)定义为任何已配发的药物和任何处方但未配发的药物。点胶误差比例=(点胶误差/OEs) × 100%。结果对照组(资料前)共观察到OEs 1028例,120例。干预组(资料后)共观察到o36例,122例患者。干预组的分配错误比例为2.2% (95% CI 1.4 ~ 3.3%)(23个错误),对照组为12.8% (95% CI 10.9 ~ 15.0)(132个错误)。组间差异有统计学意义(p=0.00)。结论及相关性与护士主导的药物调剂相比,药理学家调剂失误较少,说明药理学家调剂具有较高的患者安全性。因此,由药理学家配药可能是护士主导的药物配药的安全替代方案。参考文献和/或致谢利益冲突无利益冲突
{"title":"5PSQ-193 Patient safety in medication dispensing performed by pharmaconomists: a before and after study","authors":"C. Sorensen, L. Aggergaard, B Dorthe Krogsgaard","doi":"10.1136/EJHPHARM-2021-EAHPCONF.312","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.312","url":null,"abstract":"Background and importance High patient safety is a top priority in healthcare systems worldwide. To secure high patient safety, previous research have focused on different medication concepts (eg, automatic medication dispensing, nurse led medication dispensing or self-administration by patients). However, resources are scarce and decision makers want the most ‘value for money’. Therefore, hospital managers investigated the patient safety of medication dispensing performed by pharmaconomists (pharmacy technician with a 3 year degree (180 European credit transfer system points)) compared with nurses. Aim and objectives To evaluate patient safety of ward level medication dispensing performed by pharmaconomists compared with nurse led medication dispensing. Material and methods Medication dispensing by pharmaconomists was implemented at seven hospital wards in January 2020. The study was designed as a before and after study. The proportion of ward level dispensing errors was collected through disguised observation of nurses and pharmaconomists in the medicine room before and after implementation of pharmaconomist led medication dispensing. Before data (control group) stem from a PhD study (by the main author) at the same hospital. These data were collected in 2017–2018 by observing 37 nurses in one ward. After data (intervention group) were collected in March and June 2020. After data were collected in seven wards, to increase the number of pharmaconomists observed (9 instead of only 1) and thus increase generalisability. The collection of after data was performed over two periods due to COVID-19 restrictions at the hospital. A dispensing error was defined as a deviation between the prescription and the dispensed medication (eg, wrong dose). Opportunity for errors (OEs) was defined as any medication dispensed and any medication prescribed but not dispensed. Dispensing error proportion=(dispensing errors/OEs) × 100%. Results In the control group (before data), 1028 OEs were observed, covering 120 patients. In the intervention group (after data), 1036 OEs were observed, covering 122 patients. The dispensing error proportion was 2.2% (95% CI 1.4 to 3.3%) in the intervention group (23 errors) compared with 12.8% (95% CI 10.9 to 15.0) in the control group (132 errors). The difference between groups was statistically significant (p=0.00). Conclusion and relevance As pharmaconomists made fewer dispensing errors compared with nurse led medication dispensing, the results indicate high patient safety when medication is dispensed by pharmaconomists. Medication dispensing by pharmaconomists may therefore be a safe alternative to nurse led medication dispensing. References and/or acknowledgements Conflict of interest No conflict of interest","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"40 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83545233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-225 Implementation of a computer algorithm in the electronic health record to identify inpatients with untreated atrial fibrillation to optimise stroke prevention 4CPS-225在电子健康记录中实现计算机算法以识别未经治疗的房颤住院患者以优化卒中预防
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.57
C. Quintens, L. Linden, K. Meeusen, R. Willems, I. Spriet
{"title":"4CPS-225 Implementation of a computer algorithm in the electronic health record to identify inpatients with untreated atrial fibrillation to optimise stroke prevention","authors":"C. Quintens, L. Linden, K. Meeusen, R. Willems, I. Spriet","doi":"10.1136/EJHPHARM-2021-EAHPCONF.57","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.57","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84075683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-070 Evaluation of compatibility of acetylsalicylic acid and atenolol with medications commonly used in intensive care units 乙酰水杨酸和阿替洛尔与重症监护病房常用药物的相容性评价
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.45
A. Lombard, J. Vigneron, E. D’huart, B. Demoré
{"title":"3PC-070 Evaluation of compatibility of acetylsalicylic acid and atenolol with medications commonly used in intensive care units","authors":"A. Lombard, J. Vigneron, E. D’huart, B. Demoré","doi":"10.1136/EJHPHARM-2021-EAHPCONF.45","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.45","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81701449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-304 Rituximab as an alternative in neurologic disorders: long term study 利妥昔单抗作为神经系统疾病的替代药物:长期研究
Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.136
A. Higuera, M. Lara, C. Cuerva, I. Castillo
{"title":"4CPS-304 Rituximab as an alternative in neurologic disorders: long term study","authors":"A. Higuera, M. Lara, C. Cuerva, I. Castillo","doi":"10.1136/EJHPHARM-2021-EAHPCONF.136","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.136","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78087328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Hospital Pharmacy: Science and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1